CHFS:NSD-Nuwellis, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 4.06

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

0.04M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-08-03 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

+1.34 (+0.19%)

USD55.06B 79.31 59.42
PODD Insulet Corporation

+0.16 (+0.06%)

USD19.16B 2,202.28 159.45
ABMD Abiomed, Inc

-1.84 (-0.56%)

USD14.83B 66.22 55.76
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

-1.72 (-2.08%)

USD12.46B 62.26 31.59
TNDM Tandem Diabetes Care, Inc

-1.63 (-1.53%)

USD6.81B N/A N/A
SWAV ShockWave Medical, Inc

+0.21 (+0.12%)

USD6.37B N/A N/A
IART Integra LifeSciences Holdings ..

-0.37 (-0.52%)

USD6.12B 30.06 26.83
INMD InMode Ltd

+0.38 (+0.33%)

USD4.34B 38.00 31.47
LIVN LivaNova PLC

-4.39 (-5.00%)

USD4.23B 77.40 N/A

ETFs Containing CHFS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -41.75% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.75% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -85.97% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -85.97% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -100.00% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -100.00% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -66.73% 1% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -66.73% 1% F N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.84% 77% C+ 49% F
Risk Adjusted Return -181.15% 3% F N/A N/A
Market Capitalization 0.03B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 0.56 N/A N/A N/A N/A
Price/Book Ratio 1.75 N/A N/A N/A N/A
Price / Cash Flow Ratio -2.08 N/A N/A N/A N/A
EV/EBITDA 0.06 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -173.00% N/A N/A N/A N/A
Return on Invested Capital -186.12% N/A N/A N/A N/A
Return on Assets -83.10% N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.16 N/A N/A N/A N/A
Short Percent 1.22% N/A N/A N/A N/A
Beta 1.34 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.